We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
-6.44%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$229M
AUM Growth
-$17.6M
Cap. Flow
+$449K
Cap. Flow %
0.2%
Top 10 Hldgs %
32.31%
Holding
413
New
19
Increased
47
Reduced
82
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 14.95%
3 Miscellaneous 14.2%
4 Consumer Staples 13.87%
5 Financials 10.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
51
Novo Nordisk
NVO
$202B
$1.28M 0.56%
47,190
ETP
52
DELISTED
Energy Transfer Partners L.p.
ETP
$1.15M 0.5%
27,892
-2,317
-8% -$112K
FBIN icon
53
Fortune Brands Innovations
FBIN
$5.43B
$1.12M 0.49%
27,699
IMO icon
54
Imperial Oil
IMO
$63.1B
$1.09M 0.48%
34,465
+2,100
+6% +$72.8K
USB.PRM
55
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$1.08M 0.47%
37,550
+12,150
+48% +$349K
VNO.PRG.CL
56
DELISTED
Vornado Realty Trust
VNO.PRG.CL
$1.04M 0.46%
41,525
+7,050
+20% +$179K
PFE icon
57
Pfizer
PFE
$159B
$1.04M 0.45%
34,749
-418
-1% -$13.4K
MSFT icon
58
Microsoft
MSFT
$3.81T
$1.03M 0.45%
23,286
+2
+0% +$90
OXY icon
59
Occidental Petroleum
OXY
$59.1B
$980K 0.43%
14,835
+501
+3% +$35K
VRTX icon
60
Vertex Pharmaceuticals
VRTX
$137B
$942K 0.41%
9,050
+100
+1% +$12.8K
DE icon
61
Deere & Co
DE
$170B
$897K 0.39%
12,123
AMGN icon
62
Amgen
AMGN
$234B
$882K 0.39%
6,379
+400
+7% +$63.1K
MKC icon
63
McCormick & Company Non-Voting
MKC
$14.9B
$803K 0.35%
19,550
+6,950
+55% +$282K
MAR icon
64
Marriott International
MAR
$91.5B
$798K 0.35%
11,697
BNY
65
Bank of New York Mellon
BNY
$110B
$766K 0.33%
19,556
FPO
66
DELISTED
First Potomac Realty Trust
FPO
$755K 0.33%
68,630
-60,906
-47% -$667K
MMP
67
DELISTED
Magellan Midstream Partners, L.P.
MMP
$747K 0.33%
12,424
-600
-5% -$41K
EMB icon
68
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$672K 0.29%
6,320
-250
-4% -$27.1K
RTX icon
69
RTX Corp
RTX
$285B
$669K 0.29%
11,952
+3,575
+43% +$220K
AMBA icon
70
Ambarella
AMBA
$3.1B
$662K 0.29%
11,450
+6,100
+114% +$576K
BIIB icon
71
Biogen
BIIB
$32.3B
$659K 0.29%
2,260
+1,990
+737% +$657K
BPFHP
72
DELISTED
Boston Private Financial Holdings, Inc.
BPFHP
$594K 0.26%
23,375
+4,000
+21% +$102K
WELL icon
73
Welltower
WELL
$172B
$558K 0.24%
8,246
+2,000
+32% +$134K
MSM icon
74
MSC Industrial Direct
MSM
$6.66B
$539K 0.24%
8,835
CVE icon
75
Cenovus Energy
CVE
$58.2B
$527K 0.23%
34,769
-36,477
-51% -$514K

Similar funds

American Research & Management Company's Q3 2015 Portfolio in Review

As of Q3 2015, American Research & Management Company held 413 positions worth $229M, down 7.2% from $246M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

American Research & Management Company's Q3 2015 filing shows 19 new, 47 increased, 82 reduced and 21 closed positions. Its largest new stake was Celgene Corp: 3,970 shares worth $429K. The largest sale was State Street SPDR ICE Preferred Securities ETF, an estimated $1.87M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Miscellaneous.

  • American Research & Management Company's largest Q3 2015 buy was Celgene Corp: 3,970 shares worth $429K.
  • American Research & Management Company added most to PrivateBancorp, Inc. Capital Trust IV Trust Preferred in Q3 2015, an estimated $1.09M increase.
  • American Research & Management Company's biggest Q3 2015 reduction was State Street SPDR ICE Preferred Securities ETF, cutting an estimated $1.87M.
  • American Research & Management Company fully exited MEADWESTVACO CORP in Q3 2015, selling an estimated $293K.
  • American Research & Management Company's ten largest holdings make up 32% of its $229M portfolio in Q3 2015.
  • American Research & Management Company opened 19 new positions and closed 21 in Q3 2015.
  • American Research & Management Company's portfolio value fell 7.2% quarter-over-quarter to $229M.

Based on American Research & Management Company's 13F filing for Q3 2015, filed 20 Oct 2015.